Kiyatec Chief Scientific Officer Tessa DesRochers, PhD will speak at the 7th Tumor Models Immuno-Oncology Summit in San Francisco on January 25th, 2023. Kiyatec will be presenting – “Analyzing the modelling of T-cell specific Immuno-Therapies Deep-Diving into model applications for NK cell based therapeutics.” Using ex vivo human tumor models which incorporate tumor cells, and autologous immune cells, Kiyatec will be demonstrating the utility of their models to test T-cell specific therapies, including checkpoint inhibitors, bispecifics, and cellular therapies.